MediciNova
MNOV
$1.29
Share price
-1.53%
Change (1 day)
-38.28%
Change (1 year)
Categories
MediciNova (MNOV) - P/B ratio
P/B ratio as of April 2024 : 1.01
According to MediciNova's latest financial reports the company has a price-to-book ratio of 1.01.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
MediciNova - P/B ratio (from 2006 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.18 | -17.61% |
| 2022-12-31 | 1.43 | -8.87% |
| 2021-12-31 | 1.57 | -52.69% |
| 2020-12-31 | 3.32 | -15.97% |
| 2019-12-31 | 3.95 | -15.98% |
| 2018-12-31 | 4.70 | -22.2% |
| 2017-12-31 | 6.04 | 0.37% |
| 2016-12-31 | 6.02 | 85.48% |
| 2015-12-31 | 3.25 | -3.8% |
| 2014-12-31 | 3.38 | 78.26% |
| 2013-12-31 | 1.89 | -1.29% |
| 2012-12-31 | 1.92 | 64.79% |
| 2011-12-31 | 1.16 | -50.92% |
| 2010-12-31 | 2.37 | 11.2% |
| 2009-12-31 | 2.13 | 437.73% |
| 2008-12-31 | 0.3966 | -51.93% |
| 2007-12-31 | 0.8251 | -35.51% |
| 2006-12-31 | 1.28 | |
| 2005-12-31 | N/A | |
| 2004-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 5.02 | 394.44% | 🇨🇭 Switzerland |
 Eli Lilly LLY | 64.5 | 6,260.90% | 🇺🇸 USA |
 Sanofi SNY | 1.49 | 46.98% | 🇫🇷 France |
 Titan Pharmaceuticals
TTNP | 0.9429 | -7.04% | 🇺🇸 USA |
 Alkermes ALKS | 3.50 | 245.06% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | 1.97 | 93.76% | 🇮🇱 Israel |